Pfizer to pursue companion diagnostic for Oxford BioMedica's 5T4 programme
04 May 2011
Sukaina Virji
Please Login to read the full article.
04 May 2011
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Oxford BioMedica break-even still just out of reach
- Private equity player Celtic bankrolls new Swiss antibody-drug conjugate company
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
- Investors look for better efficacy from safe cancer immunotherapies
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
